CEBPZ and acute myeloid leukemia: Although the prognosis of CBF‐AML is better than other subtypes of AML, approximately 30%‐40% of the patients still relapse and may require allogeneic hematopoietic cell transplantation (HCT).6, 7, 8 A scoring system to predict who has a higher risk of relapse at the time of diagnosis may be clinically valuable to guide decision‐making.